Met proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms.
Hansel
Donna E
DE
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Rahman
Ayman
A
House
Michael
M
Ashfaq
Raheela
R
Berg
Karin
K
Yeo
Charles J
CJ
Maitra
Anirban
A
D000368:Aged; D002454:Cell Differentiation; D004247:DNA / Q000378:metabolism; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000096:biosynthesis*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D018358:Neuroendocrine Tumors / Q000378:metabolism*; D010190:Pancreatic Neoplasms / Q000378:metabolism*; D000090063:Proto-Oncogene Mas; D019859:Proto-Oncogene Proteins c-met / Q000096:biosynthesis*; D012313:RNA / Q000378:metabolism; D015854:Up-Regulation
D018972:Insulin-Like Growth Factor Binding Protein 3; C000715470:MAS1 protein, human; D000090063:Proto-Oncogene Mas; D012313:RNA; D004247:DNA; D019859:Proto-Oncogene Proteins c-met